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TABLE 1. Characteristics of patients and data of recurrence, metastasectomy, survival time
Patient 1 2 3 4 5
Gender Male Male Male Male Male
Age, y 49 66 47 63 37
Thoracic recurrence
Location RUL, RLL RLL RCC, RLL RML RUL
Size (cm) 1, 2 3.5 5, 0.5 3 1
Resection Wedge Lobectomy Rib resection, Lobectomy Wedge Wedge
Tumor differentiation grade Low, low Low Low, benign Low Low
Postresection treatment No No No No No
Secondary recurrence No Yes No No No
Location — Left adrenal gland — — —
Size (cm) — 3 — — —
Resection — Laparoscope — — —
Tumor differentiation grade — Low — — —
Postresection treatment — No — — —
Alive Yes Yes Yes Yes Yes
Time from transplant (mo)
to thoracic recurrence 32 33 12 8 11
to secondary recurrence — 39 — — —
Survival time from TRR (mo) 53 16 8 9 3
RUL, Right upper lobe; RLL, right lower lobe; RCC, right costal cartilage; RML, right middle lobe; TRR, thoracic recurrence resection.
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Failure trial.1 EPP can provide restoration of left ventricular
(LV) size and geometry by excluding nonviable areas. At
present, the differentiation of viable tissue and scar tissue
is based on using subjective methods to assess morphologic
features, such as consistency, thickness, and color of the
wall, and it might be inadequate on the surgical table. We as-
sessed the feasibility of in vivo radio-guided surgery (RGS)
with a gamma probe as an objective tool to differentiate
viable tissue and scar tissue in patients undergoing EPP.
CLINICAL SUMMARY
Two patients with previous anterior myocardial infarc-
tions were selected for LVR (Table 1). Informed consentardiovascular Surgery c Volume 138, Number 1 241
Brief Technique Reportsand the approval of the local ethics committee were ob-
tained. One week before LVR, patients underwent gated sin-
gle-photon emission computed tomography (SPECT) with
Tc-99m sestamibi to assess myocardial perfusion and LV
function.2 Twelve hours before LVR, the same imaging pro-
tocol was repeated for the in vivo analysis of tracer distribu-
tion during EPP. RGS was performed with a gamma probe
(Breast Care Unit; Neoprobe Corp, Dublin, Ohio) with a spa-
tial resolution of 3 mm.3 SPECT was repeated 6 months later
to assess the effects of LVR on myocardial perfusion and LV
function.
Both patients underwent LVR, according to the procedure
of Dor and colleagues.4 After cardiac arrest, the scarred/
viable junction was evaluated in conjunction with the stan-
dard approach, based on subjective patterns, by means of
a continuous counting rate of gamma radiation measured
in counts per second and updated every half-second. Tissue
characterization with the gamma probe was performed both
on epicardial and endocardial LV surfaces after incision of
the necrotic anteroapical wall segment (Figure 1). Thereaf-
ter, an encircling suture at the scarred/viable junction was
obtained to exclude the fibrotic segments from the ventricu-
lar cavity, creating an approximately 3-cm pursed opening.
In the end, an oval synthetic patch closed the ventricular
opening, folding the excluded scar over the patch to ensure
hemostasis.
At presurgical SPECT, in both patients the lowest tracer
uptake was observed in the anteroapical region (15% of
peak activity in patient 1 and 12% in patient 2). LV function
in patient 1 is shown in Figure 2. In agreement with presur-
gical SPECT, a similar pattern was observed at the gamma
probe, with the lowest count rate being approximately 30
to 40 cps. The surgeon also deemed these segments, using
subjective standard methods, to be the center of the LV non-
viable area. By using the gamma probe, 2.5 up to 6 ratios be-
tween viable and necrotic myocardium, as visually defined
by the surgeon, was determined in both patients. Such a dif-
ferent count rate increased the surgeon’s self-confidence to
trace the borders between the scar tissue and viable tissue.
The highest value of viable/necrotic count ratio was ob-
served with the probe inside the ventricular chamber, laying
on the endocardial surface, and away from the patient’s
TABLE 1. Demographic data and clinical characteristics of the
patients
Patient 1 Patient 2
Age (y) 62 63
Sex Male Male
Prior myocardial infarction Anterior Anterolateral
Angina Yes No
Left ventricular ejection fraction (%) 20 35
NYHA class III III
Grafts (n) 1 3
NYHA, New York Heart Association.242 The Journal of Thoracic and Cardiovascular Subackground. Conversely, high background levels of up to
350 cps were recorded when the probe in contact with the
epicardial surface was directed toward the subdiaphragmatic
organs, mainly related to bowel radioactivity. The whole
procedure did not require significant time on the surgical ta-
ble, being less than 5 minutes for both patients.
SPECT performed 6 months after LVR demonstrated a re-
duction in the extent and degree of perfusion defects in both
patients. An improvement in ejection fraction was observed
in both patients (from 21% to 43% in patient 1 and from
36% to 53% in patient 2). Postsurgical LV function in pa-
tient 1 is shown in Figure 2.
FIGURE 1. Radio-guided surgery during left ventricular remodeling. In
vivo analysis of tracer distribution for the differentiation between viable tis-
sue and scar tissue was performed on the epicardial (A and B) and endocar-
dial (C) surfaces of the ventricular chamber.rgery c July 2009
Brief Technique ReportsFIGURE 2. Presurgical (A) and postsurgical (B) left ventricular volume in end-diastole (EDV) and end-systole (ESV) in patient 1. Restoration of ventricular
size and shape resulted in an improvement in stroke volume (SV) and ejection fraction (EF).DISCUSSION
This is the first report demonstrating the feasibility of
RGS with labeled cardiac perfusion agents. RGS allowed
us to reach an effective difference in count rates deriving
from viable tissue and scar tissue. The surgeon reported an
improvement in his self-confidence for defining transitional
zone between scar and viable tissue with respect to the stan-
dard approach. Furthermore, RGS did not affect the duration
of the surgical procedure. The therapeutic efficacy was
documented in both patients. In fact, the extent and degree
of perfusion defects and of areas of akinesia were reduced
after RGS.
Over the last decade, RGS has undergone continuous
growth, with application in several fields, mostly related to
malignant diseases. RGS implies the use of a gamma-probe
to count the radioactivity derived by tissues concentrating
the administered tracer. Because of the high spatial resolu-
tion and sensitivity, gamma probes are able to detect small
sources of radioactivity and to distinguish radioactive tissue
from close areas without significant uptake of gamma emit-
ters.3 Cellular uptake and retention of myocardial perfusion
agents, such as sestamibi, are expressions of preserved my-The Journal of Thoracic andocyte viability.2 Conversely, necrotic or fibrotic areas are
unable to extract and retain the tracers.5 On this basis, the
gamma probe provides the possibility to characterize viabil-
ity in vivo.
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